Albert D. Dyrness Sonnet Bio Therapeutics Holdings, Inc. (SONN) insider trading activity

SONN Quotes by TradingView

Albert D. Dyrness is Director of Sonnet BioTherapeutics Holdings, Inc.. Currently has a direct ownership of 537 shares of SONN, which is worth approximately $2,432. The most recent transaction as insider was on Dec 11, 2023, when has been sold 373 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 537
0% 3M change
0% 12M change
Total Value Held $2,432

Albert D. Dyrness Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2023
BUY
Grant, award, or other acquisition
-
373 Added 40.99%
537 Common Stock
Jul 11 2023
BUY
Grant, award, or other acquisition
-
4,000 Added 46.85%
4,537 Common Stock
May 30 2023
BUY
Open market or private purchase
$10,929 $0.47 p/Share
23,255 Added 44.54%
28,962 Common Stock
Dec 14 2022
BUY
Grant, award, or other acquisition
-
3,770 Added 10.88%
30,893 Common Stock
Dec 15 2021
BUY
Grant, award, or other acquisition
-
14,152 Added 34.29%
27,123 Common Stock
ADD

Albert D. Dyrness

Director
Princeton,, NJ

Track Institutional and Insider Activities on SONN

Follow Sonnet BioTherapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SONN shares.

Notify only if

Insider Trading

Get notified when an Sonnet Bio Therapeutics Holdings, Inc. insider buys or sells SONN shares.

Notify only if

News

Receive news related to Sonnet BioTherapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SONN